rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1996-11-20
|
pubmed:abstractText |
The pattern of sensorineural hearing loss (SNHL) after primary treatment for nasopharyngeal carcinoma (NPC) was studied, and the effect of cisplatin, radiotherapy does, and fractionation were evaluated.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0360-3016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
281-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8892450-Adolescent,
pubmed-meshheading:8892450-Adult,
pubmed-meshheading:8892450-Aged,
pubmed-meshheading:8892450-Antineoplastic Agents,
pubmed-meshheading:8892450-Cisplatin,
pubmed-meshheading:8892450-Combined Modality Therapy,
pubmed-meshheading:8892450-Female,
pubmed-meshheading:8892450-Hearing Loss, Sensorineural,
pubmed-meshheading:8892450-Humans,
pubmed-meshheading:8892450-Male,
pubmed-meshheading:8892450-Middle Aged,
pubmed-meshheading:8892450-Multivariate Analysis,
pubmed-meshheading:8892450-Nasopharyngeal Neoplasms,
pubmed-meshheading:8892450-Otitis Media with Effusion,
pubmed-meshheading:8892450-Prospective Studies,
pubmed-meshheading:8892450-Radiation-Sensitizing Agents,
pubmed-meshheading:8892450-Sex Factors
|
pubmed:year |
1996
|
pubmed:articleTitle |
Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
|
pubmed:affiliation |
Department of Radiotherapy and Oncology, University of Hong Kong, Queen Mary Hospital, Hong Kong.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|